Search results
'Exciting' new Parkinson's treatment may cure root cause
Newsweek· 3 days agoAn "exciting" new Parkinson's disease drug promises to not only treat but to cure the condition at...
The regionality and seasonality of tornado trends in the United States - npj Climate and Atmospheric...
Nature· 2 days ago1, and defined a tornado day as any calendar day with at least one (E)F-1+ tornado, and a tornado outbreak day as any day with more than 30 (E)F-1+ tornadoes1. Over the 63-year period of our ...
Lilly’s Phase II results in Alzheimer’s disease have most experts saying donanemab is done
Clinical Trials Arena via Yahoo Finance· 7 days agoEli Lilly’s donanemab for early symptomatic Alzheimer’s disease (AD) has most experts dubious of the...
Removal of ovaries before menopause associated with reduced white matter in brain
Medical Xpress· 3 days ago"We know that having both ovaries removed before natural menopause causes abrupt endocrine...
Intra-Cellular Therapies' Highlights Successful Data From Second Depression Study - Intra-Cellular...
Benzinga· 5 days agoLumateperone 42 mg, given once daily as adjunctive therapy to antidepressants, met the primary...
3 Stocks That Have Soared 179% or More in 2024 and Could Go Even Higher, According to Wall Street
Motley Fool via Yahoo Finance· 6 days agoIn this study, which was conducted in China, patients receiving the ivonescimab/chemo combo achieved...
Intra-Cellular (ITCI) Up as Second Depression Study Meets Goals
Zacks via Yahoo Finance· 4 days agoIntra-Cellular (ITCI) gains 10% after achieving key goals in the second late-stage study evaluating...
Marinus Pharmaceuticals Shares Mixed Results From IV Formulated Ganaxolone In Pretreated Seizure...
Benzinga· 6 days agoMonday, Marinus Pharmaceuticals Inc MRNS announced topline results from the Phase 3 RAISE trial...
Brain may shrink after surgical menopause, doctors warn
Newsweek· 3 days agoRemoving both of a woman's ovaries before natural menopause may reduce the integrity of white matter...
Japan Pharma Giant Takeda's Anti-Seizure Treatment Flunks In Two Late-Stage Studies What's Going On...
Benzinga· 6 days agoMonday, Takeda Pharmaceutical Co Ltd TAK announced topline data from its SKYLINE and SKYWAY Phase 3...